Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA5A | P35218 | 2/20 | 0.56 |
| ▸ | ACHE | P22303 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 3/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | HSD17B1 | P14061 | 3/20 | 0.39 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | FUT7 | Q11130 | 2/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | CA3 | P07451 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10066339 | 0.88 | CA5A (0.50) | CA5AACHELMNACYP3A4HPGD | |
| SCHEMBL11305809 | 0.84 | PRKCI (0.47) | CA5AACHELMNACYP3A4HPGD | |
| SCHEMBL96069 | 0.81 | LMNA (0.59) | CA5ALMNAHPGDKDM4EFUT7 | |
| SCHEMBL19622609 | 0.81 | CA5A (0.43) | CA5AACHELMNACYP3A4HPGD | |
| SCHEMBL22917564 | 0.80 | POLB (0.60) | CA5ALMNAKDM4EFUT7TDP1 | |
| SCHEMBL1919748 | 0.79 | CA12 (0.64) | CA5AACHELMNAHPGDPKM | |
| SCHEMBL13144722 | 0.78 | CA5A (0.50) | CA5ALMNACYP3A4HPGDMEN1 | |
| SCHEMBL31500495 | 0.77 | CA5A (0.54) | CA5ALMNACYP3A4HPGDMEN1 | |
| Water SCHEMBL4387068 | 0.77 | CA12 (0.61) | CA5AACHELMNAHPGDPKM | |
| Water SCHEMBL4387073 | 0.77 | CA12 (0.61) | CA5AACHELMNAHPGDPKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11912736-B2 | Diaryl trehalose compounds and uses thereof | THE UNIVERSITY OF MONTANA (US) | 2024-02-27 | — | — | US | disclosed |
| US-9629863-B2 | CDK5 inhibitors and therapeutic uses thereof | THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2017-04-25 | — | — | US | disclosed |
| US-9237996-B2 | Glucosyltransferase inhibitor containing epigallocatechin gallate polymer as active ingredient | SUNTORY HOLDINGS LIMITED (JP) | 2016-01-19 | — | — | US | disclosed |
| US-8575368-B2 | Proanthocyanidin of cashew apple, composition containing proanthocyanidin, and application thereof | Nichirei Biosciences, Inc. (JP) | 2013-11-05 | — | — | US | disclosed |
| US-20120095063-A1 | METHODS AND COMPOSITIONS FOR TREATMENT OF ISCHEMIC CONDITIONS AND CONDITIONS RELATED TO MITOCHONDRIAL FUNCTION | CARDERO THERAPEUTICS, INC. | 2012-04-19 | — | — | US | disclosed |
| US-20110263698-A1 | PROANTHOCYANIDIN OF CASHEW APPLE, COMPOSITION CONTAINING PROANTHOCYANIDIN, AND APPLICATION THEREOF | Nichirei Biosciences, Inc. (JP) | 2011-10-27 | — | — | US | disclosed |
| US-20110150790-A1 | GLUCOSYLTRANSFERASE INHIBITOR CONTAINING EPIGALLOCATECHIN GALLATE POLYMER AS ACTIVE INGREDIENT | SUNTORY HOLDINGS LIMITED (JP) | 2011-06-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110150790-A1 | GLUCOSYLTRANSFERASE INHIBITOR CONTAINING EPIGALLOCATECHIN GALLATE POLYMER AS ACTIVE INGREDIENT | UGGT1, B4GALT1, MGAT1 | CA5A 4362/4885ACHE 1232/4885LMNA 4036/4885 |
| US-20120095063-A1 | METHODS AND COMPOSITIONS FOR TREATMENT OF ISCHEMIC CONDITIONS AND CONDITIONS RELATED TO MITOCHONDRIAL FUNCTION | MT-ND1, MT-ND2, MT-CO3 | CA5A 166/4885ACHE 2768/4885LMNA 801/4885 |
| US-20110263698-A1 | PROANTHOCYANIDIN OF CASHEW APPLE, COMPOSITION CONTAINING PROANTHOCYANIDIN, AND APPLICATION THEREOF | AMY1A, AMY2A, PEPD | CA5A 3094/4885ACHE 65/4885LMNA 1065/4885 |
| US-11912736-B2 | Diaryl trehalose compounds and uses thereof | TREH, STT3B, DDOST | CA5A 2333/4885ACHE 616/4885LMNA 4611/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.